The recent AdenosINe Sestamibi Post-InfaRction Evaluation (INSPIRE, Figure 6) trial assessed MPI for defining initial patient risk and in guiding therapy in stable survivors of acute MI. [9] The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback